BPC-157 (5mg-10mg), Body Protection Compound 157 A Pentadecapeptide of Gastric Origin Introduction A Pentadecapeptide of Gastric Origin BPC-157 is a synthetic 15-residue peptide derived from a partial sequence identified within a larger gastric protective protein originally isolated from human gastric juice in the mid-1990s by Sikiric and colleagues at the University of Zagreb
TABLE 2 Pharmacokinetic parameters of BPC157 in rats following intramuscular administrations of doses ranging between 5 and 120 g/kg (mean SD, n = 6)
It is crucial to follow the veterinarian's instructions regarding dosage, frequency, and duration of treatment to ensure optimal results
However, the specific mechanisms underlying the changes in calcium oscillations and biomarker levels observed in the study are unclear, and the effects of SSRIs on long-term cardiomyocyte functions, such as contractile activity or electrophysiological properties, have not been assessed
In sporadic cases, allergic reactions may occur